Evidence map›Paper›PMID 30003062›Full record

ArticleFrontiers in oncology2018

Testing of a Tool for Prostate Cancer Screening Discussions in Primary Care.

Anita D Misra-Hebert, Grant Hom, Eric A Klein, Janine M Bauman, Niyati Gupta, Xinge Ji, Andrew J Stephenson, J Stephen Jones, Michael W Kattan

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Anita D Misra-HebertDepartment of Internal Medicine, Cleveland Clinic, Cleveland, OH, United States.
Grant HomCase Western Reserve University, Cleveland, OH, United States.
Eric A KleinGlickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, United States.
Janine M BaumanDepartment of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, United States.
Niyati GuptaCenter for Value-Based Care Research, Cleveland Clinic, Cleveland, OH, United States.
Xinge JiDepartment of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, United States.
Andrew J StephensonGlickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, United States.
J Stephen JonesGlickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, United States.
Michael W KattanDepartment of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, United States.
Cleveland Clinic · USCase Western Reserve University · US

Funding

Impact of a Team-based Approach to Primary Care: A Natural Experiment in Primary Care RedesignK08HS024128 · AHRQ · CLEVELAND CLINIC FOUNDATION · PI MISRA-HEBERT, ANITA DIANA · 2016 to 2020
$738k
AHRQ HHS K08 HS024128
6 · The paper itself

Abstract

backgroundAs prostate cancer (PCa) screening decisions often occur in outpatient primary care, a brief tool to help the PCa screening conversation in busy clinic settings is needed.

methodsA previously created 9-item tool to aid PCa screening discussions was tested in five diverse primary care clinics. Fifteen providers were recruited to use the tool for 4 weeks, and the tool was revised based upon feedback. The providers then used the tool with a convenience sample of patients during routine clinic visits. Pre- and post-visit surveys were administered to assess patients' knowledge of the option to be screened for PCa and of specific factors to consider in the decision. McNemar's and Stuart-Maxwell tests were used to compare pre-and post-survey responses.

results14 of 15 providers completed feedback surveys and had positive responses to the tool. All 15 providers then tested the tool on 95 men aged 40-69 at the five clinics with 2-10 patients each. The proportion of patients who strongly agreed that they had the option to choose to screen for PCa increased from 57 to 72% (

conclusionA brief conversation tool for the PCa screening discussion was well received in busy primary-care settings and improved patients' knowledge about the screening decision.

Indexed as

cancer screeningclinical decision-makingprostate cancerprostate-specific antigenshared decision-making

Identifiers

PMID30003062
PMCPMC6031706
OpenAlexW2809213586

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.